Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Costco Wholesale Corporation (COST) Stock: The Danger Is Growing

By Dana Blankenhorn, InvestorPlace Contributor
Costco (COST) is, at heart, a slow-growing company. Increased membership fees will help the bottom line, but COST stock is still too rich.

Nvidia Corporation (NVDA) Stock Is Wilting. Sell It Now!

By Anthony Mirhaydari, InvestorPlace Market Strategist
After putting up 220%-plus gains in 2016, Nvidia (NVDA) is sparring with a much-stronger shadow. Time to sell NVDA stock before it wilts.

BlackBerry Ltd (BBRY): The Game Clock Is Ticking Down to Zero

By James Brumley, InvestorPlace Feature Writer
BlackBerry (BBRY) has given its turnaround effort the 'old college try,' but the scoreboard - the BlackBerry stock chart - doesn't lie.

Nokia Corp (ADR) (NOK) Stock Is Charming, But It’s Still Fool’s Gold

By Josh Enomoto, InvestorPlace Contributor
Nokia has been a real charmer in the markets this year. But NOK stock's ugly fundamentals represent a big distraction for investors.

5 Blue-Chip Stocks to Sell in March

By Anthony Mirhaydari, InvestorPlace Market Strategist
It may seem counterintuitive to bet against record-setting markets, but these five blue-chip stocks are about to get smacked by headwinds.

Is General Electric Company (GE) Stock In Trouble Thanks to Trump?

By Richard Saintvilus, InvestorPlace Contributor
General Electric's (GE) revenue strength might now be its biggest weakness. Here's what GE stock investors need to know.

Sell the Bounce In Fitbit Inc (FIT) Stock

By Vince Martin, InvestorPlace Contributor
Fitbit Inc might look cheap, but it isn't. An unprofitable business and increasing competition mean FIT stock still has more downside.

The Bank of America Corp (BAC) Stock Rally Is Nearing Its End

By Dana Blankenhorn, InvestorPlace Contributor
Bank of America (BAC) is up 45% in hope of earnings gains that have not yet come. That could end up biting BAC stock, and sooner than later.

3 Dow Jones Stocks That Are Set Up for Failure

By Anthony Mirhaydari, InvestorPlace Market Strategist
With the Dow Jones' record uptrend at risk, these three stocks look vulnerable to a nasty pullback as momentum fades.

Don’t Waste Any More Time on Valeant Pharmaceuticals Intl Inc (VRX) Stock

By Dana Blankenhorn, InvestorPlace Contributor
Valeant (VRX) is in the position of a losing gambler trying to hock a watch, but VRX stock isn't going to fetch the price it wants.

Leave Sears Holdings Corp (SHLD) Stock to the Savages

By Dana Blankenhorn, InvestorPlace Contributor
Sears stock is undergoing a slow-motion liquidation while SHLD investors ask if there is even $1 billion in equity value left.

Target Corporation (TGT) Stock Is Even Worse Than Q4 Earnings Suggest

By James Brumley, InvestorPlace Feature Writer
Target (TGT) fell sharply following its Q4 earnings release, but the story behind TGT stock might be even worse than the raw numbers.

8 of the Most Overrated Stocks on Wall Street Right Now

By James Brumley, InvestorPlace Feature Writer
Some stocks are graded fairly, but a handful of the most overrated stocks deserve to be called out -- and sold sooner than later.

Valeant Pharmaceuticals Intl Inc (VRX) Stock Is the Twitter Inc (TWTR) of Pharma

By Josh Enomoto, InvestorPlace Contributor
The air is rife with comeback stories, but Valeant Pharmaceuticals faces an obscenely difficult task in returning VRX stock to greatness.

Valeant Pharmaceuticals Intl Inc (VRX) Q4 Earnings: What to Expect

By Richard Saintvilus, InvestorPlace Contributor
Valeant Pharmaceuticals (VRX) needs too many things to go right to emerge strong in 2017. VRX stock just doesn't control its own destiny.

Buy Fitbit Inc (FIT) Trackers, But Not Fitbit Stock

By Will Ashworth, InvestorPlace Contributor
Whether Fitbit (FIT) is at $5 or $50, investing in the future of Fitbit stock is a crap shoot at best, and a recipe for calamity at worst.

7 REITs That Should Be Condemned

By Louis Navellier, Editor, Growth Investor
REITs are set up so that they're required to pay out 90% of their income to shareholders. But beware: Not all REITs were created equal.

Why Freeport-McMoRan Inc (FCX) Stock Is Much Uglier Without Indonesia

By James Brumley, InvestorPlace Feature Writer
Freeport McMoRan (FCX) flinched first, effectively conceding that Indonesian regulators were holding all the cards with Papua's copper mine.

Should You Buy L Brands Inc Stock on the Dip? (LB)

By Louis Navellier, Editor, Growth Investor
L Brands recent earnings came in at expectations, but future guidance numbers have scared away investors in LB stock
Load More Articles